Pharma Mar, S.A. (LON:0RC6)

Pharma Mar Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,101	1,149	641	1,027	867	1,177
Market Cap Growth	175.68%	79.24%	-37.61%	18.42%	-26.28%	75.82%
Enterprise Value	1,026	1,073	527	900	728	1,054
Last Close Price	62.57	65.79	35.39	55.59	45.92	61.19
PE Ratio	66.23	53.17	649.51	23.46	11.12	9.57
PS Ratio	7.49	7.94	4.67	5.90	4.49	4.87
PB Ratio	6.67	6.67	3.82	5.19	5.81	12.78
P/TBV Ratio	6.70	6.70	3.84	5.22	5.84	12.91
P/FCF Ratio	-	-	-	39.30	57.78	4.76
P/OCF Ratio	-	230.47	-	30.22	40.22	4.71
EV/Sales Ratio	6.89	7.42	3.84	5.17	3.77	4.36
EV/EBITDA Ratio	87.44	128.91	-	22.60	9.12	7.39
EV/EBIT Ratio	157.61	200.70	-	24.11	9.37	7.51
EV/FCF Ratio	-68.92	-	-	34.42	48.46	4.26
Debt / Equity Ratio	0.26	0.25	0.23	0.19	0.28	0.55
Debt / EBITDA Ratio	3.75	4.19	48.68	0.91	0.51	0.35
Debt / FCF Ratio	-	-	-	1.45	2.76	0.21
Asset Turnover	0.53	0.51	0.43	0.52	0.66	1.19
Inventory Turnover	0.21	0.18	0.29	0.71	1.46	1.32
Quick Ratio	2.23	2.29	1.98	2.18	2.93	2.31
Current Ratio	2.97	3.03	2.63	2.83	3.42	2.59
Return on Equity (ROE)	10.19%	13.00%	0.55%	24.62%	66.18%	249.16%
Return on Assets (ROA)	1.44%	1.17%	-0.65%	6.91%	16.54%	43.04%
Return on Capital (ROIC)	1.99%	1.63%	-0.95%	10.67%	29.89%	77.41%
Return on Capital Employed (ROCE)	3.00%	2.40%	-	14.20%	32.80%	66.60%
Earnings Yield	1.51%	1.88%	0.15%	4.26%	8.99%	10.45%
FCF Yield	-1.35%	-0.65%	-3.83%	2.54%	1.73%	21.01%
Dividend Yield	0.74%	1.01%	1.59%	1.04%	1.19%	0.88%
Payout Ratio	57.46%	43.71%	1028.06%	23.83%	11.71%	6.42%
Buyback Yield / Dilution	-	1.98%	0.81%	0.12%	1.31%	0.77%
Total Shareholder Return	0.74%	2.98%	2.41%	1.16%	2.50%	1.65%

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.